PathogenDX

PathogenDX

PathogenDX

Delivering disruptive testing technology and solutions to the botanical, food and agricultural markets at breakthrough simplicity and costeffectiveness
Raised
$7.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$7,500,000
Venture capital (Series B) - 2019
Salveo Capital Cresco Capital Partners Altitude Investment Management +3
Undisclosed amount
Undisclosed funding - 2018
Salveo Capital
Team Size
1–10
Employees
$7,500,000 Venture capital (Series B)
Forbes

Revolutionary Company PathogenDx Announces $7.5 Million In Series B Funding

Undisclosed funding
FinSMEs

PathogenDx Receives Investment from Salveo Capital

Energy
PE HUB

Salveo Capital invests in PathogenDx

Funding Apps & Services Health